HC Wainwright & Co. Downgrades Interpace Biosciences to Neutral
HC Wainwright & Co. analyst Yi Chen downgrades Interpace Biosciences (OTC:IDXG) from Buy to Neutral.
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
All news is property of their respective owners.
